Works matching IS 0195668X AND DT 2022 AND VI 43 AND IP 31
Results: 18
far-reaching beneficial effects of sodium–glucose co-transporter 2 inhibitors in heart failure.
- Published in:
- European Heart Journal, 2022, v. 43, n. 31, p. 2907, doi. 10.1093/eurheartj/ehac437
- By:
- Publication type:
- Article
What cardiologists should know about sleep.
- Published in:
- European Heart Journal, 2022, v. 43, n. 31, p. 2911, doi. 10.1093/eurheartj/ehac349
- By:
- Publication type:
- Article
UK TAVI trial: an independent, pragmatic study extending the evidence for the treatment of symptomatic severe aortic stenosis.
- Published in:
- European Heart Journal, 2022, v. 43, n. 31, p. 2919, doi. 10.1093/eurheartj/ehac345
- By:
- Publication type:
- Article
Left main revascularization: breaking through the sounds of silence.
- Published in:
- European Heart Journal, 2022, v. 43, n. 31, p. 2998, doi. 10.1093/eurheartj/ehac340
- By:
- Publication type:
- Article
Post-operative AF and heart failure hospitalizations: what remains hidden in patients undergoing surgery.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
sounds of silence.
- Published in:
- European Heart Journal, 2022, v. 43, n. 31, p. 2997, doi. 10.1093/eurheartj/ehac333
- By:
- Publication type:
- Article
Popeye's sign and transthyretin amyloidosis.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Paroxysmal massive mitral regurgitation.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Frankfurt scientists lead the way with funding for three visionary research projects.
- Published in:
- European Heart Journal, 2022, v. 43, n. 31, p. 2914, doi. 10.1093/eurheartj/ehac316
- By:
- Publication type:
- Article
Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled.
- Published in:
- European Heart Journal, 2022, v. 43, n. 31, p. 2984, doi. 10.1093/eurheartj/ehac306
- By:
- Publication type:
- Article
Emerging role for SGLT2 inhibitors in mitigating the risk of hyperkalaemia in heart failure.
- Published in:
- European Heart Journal, 2022, v. 43, n. 31, p. 2994, doi. 10.1093/eurheartj/ehac304
- By:
- Publication type:
- Article
Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease.
- Published in:
- European Heart Journal, 2022, v. 43, n. 31, p. 2931, doi. 10.1093/eurheartj/ehac299
- By:
- Publication type:
- Article
Post-operative atrial fibrillation and risk of heart failure hospitalization.
- Published in:
- European Heart Journal, 2022, v. 43, n. 31, p. 2971, doi. 10.1093/eurheartj/ehac285
- By:
- Publication type:
- Article
multinational European network to implement integrated care in elderly multimorbid atrial fibrillation patients: the AFFIRMO Consortium.
- Published in:
- European Heart Journal, 2022, v. 43, n. 31, p. 2916, doi. 10.1093/eurheartj/ehac265
- By:
- Publication type:
- Article
Obesity, heart failure, and SGLT2 inhibition: DECLARE-TIMI 58 provides insights.
- Published in:
- European Heart Journal, 2022, v. 43, n. 31, p. 2968, doi. 10.1093/eurheartj/ehab709
- By:
- Publication type:
- Article
Obesity and effects of dapagliflozin on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus in the DECLARE–TIMI 58 trial.
- Published in:
- European Heart Journal, 2022, v. 43, n. 31, p. 2958, doi. 10.1093/eurheartj/ehab530
- By:
- Publication type:
- Article
Anti-interleukin-1 agents for pericarditis: a primer for cardiologists.
- Published in:
- European Heart Journal, 2022, v. 43, n. 31, p. 2946, doi. 10.1093/eurheartj/ehab452
- By:
- Publication type:
- Article
Critical appraisal of artificial intelligence-based prediction models for cardiovascular disease.
- Published in:
- European Heart Journal, 2022, v. 43, n. 31, p. 2921, doi. 10.1093/eurheartj/ehac238
- By:
- Publication type:
- Article